Impact of holding home stimulant(s) on agitation in a child and adolescent inpatient psychiatric population
Open Access
- 1 March 2021
- journal article
- research article
- Published by American Association of Psychiatric Pharmacists (AAPP) in Mental Health Clinician
- Vol. 11 (2) , 50-54
Abstract
This study aimed to compare the rates of agitation-related interventions associated with initial holding versus continuation of home stimulant(s) in a child and adolescent population at the time of admission to an inpatient psychiatric facility. This retrospective chart review included patients less than 18 years of age who were admitted to an academic medical center between July 1, 2017, and July 1, 2018. Patients were divided into 2 groups: those continued on their home stimulant(s) and those who had them held. We compared both groups on agitation-related outcomes by examining the difference in the number of level I or II events or as-needed medication administrations. Mechanical restraints and closed-door seclusions were grouped as level I events, and level II events consisted of nonmechanical restraint. The analysis included 169 patients. In total, 126 (75%) patients were continued on their home stimulant, and 43 (25%) had them held. The occurrence of the composite endpoint of level I or II events or as-needed intramuscular medication administration was numerically higher in the group that had their home stimulant held (27.9% vs 23%; P = .52). Level I events were also numerically higher but not statistically significant in the group that had their home stimulant held (16.3% vs 11.9%; P = .46). The composite outcome of as-needed intramuscular medication administration and level I or II events was numerically higher in the group that had their home stimulant held. Use of a larger sample size and adjusted analyses may help elucidate covariates that impact agitation-related outcomes.Keywords
This publication has 11 references indexed in Scilit:
- De-escalation of aggressive behaviour in healthcare settings: Concept analysisInternational Journal of Nursing Studies, 2017
- The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar DisorderAmerican Journal of Psychiatry, 2017
- Diagnostic and Statistical Manual of Mental Disorders2013
- Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin tossBMC Health Services Research, 2012
- Methylphenidate and Risk of Serious Cardiovascular Events in AdultsAmerican Journal of Psychiatry, 2012
- Prevalence and Precursors of the use of Restraint and Seclusion in a Private Psychiatric Hospital: Comparison of Child and Adolescent PatientsAdministration and Policy in Mental Health and Mental Health Services Research, 2011
- ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and AdolescentsPediatrics, 2011
- Alpha-2 Adrenergic Receptors and Attention-Deficit/Hyperactivity DisorderCurrent Psychiatry Reports, 2010
- Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and AdultsJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Paradoxical reactions to benzodiazepines in intravenous sedation: a report of 2 cases and review of the literature.2002